Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma

Maria Stella De Mitri, Romina Cassini, Sabrina Bagaglio, Giulia Morsica, Pietro Andreone, Nicoletta Marino, Mauro Bernardi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The interaction between the hepatitis C virus (HCV) non-structural 5A (NS5A) protein of HCVand the protein kinase R (PKR), which is an effector of the cellular antiviral response and has been defined as a tumour suppressor, may affect the control of protein synthesis and cell growth. Aim: We investigated the genetic evolution of the NS5A region in the NS5A PKR-binding domain (NS5APKRbd) of patients with HCV 1b-related cirrhosis who subsequently developed or not hepatocellular carcinoma (HCC). Patients and Methods: The quasispecies composition of NS5A-PKRbd was inferred by sequencing an average of 15 clones per sample in specimens obtained from 26 patients with cirrhosis who developed or not HCC during a follow-up of 5 years. Results: At baseline, 13/17 patients with final HCC and six out of nine patients with cirrhosis who subsequently did not develop HCC harboured a wild-type (wt) strain master sequence. Over time, the prevalence of wt strain was higher in patients who developed HCC with respect to those who maintained the cirrhosis status (15/17 vs 4/9, respectively; P = 0.0166). Conclusion: The maintenance of or evolution to the wt strain of the NS5A domain in cirrhotic patients with final HCC highlights the central role of NS5A protein in the viral life cycle and in the progression of liver disease.

Original languageEnglish
Pages (from-to)1126-1133
Number of pages8
JournalLiver International
Volume27
Issue number8
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Hepacivirus
Liver Diseases
Hepatocellular Carcinoma
Fibrosis
Genes
Protein Kinases
Molecular Evolution
Viral Proteins
Life Cycle Stages
Antiviral Agents
Proteins
Clone Cells
Maintenance
Growth
Neoplasms

Keywords

  • Cirrhosis
  • Hepatitis C virus
  • Hepatocellular carcinoma
  • Non-structural 5 A protein

ASJC Scopus subject areas

  • Hepatology

Cite this

Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma. / De Mitri, Maria Stella; Cassini, Romina; Bagaglio, Sabrina; Morsica, Giulia; Andreone, Pietro; Marino, Nicoletta; Bernardi, Mauro.

In: Liver International, Vol. 27, No. 8, 10.2007, p. 1126-1133.

Research output: Contribution to journalArticle

De Mitri, Maria Stella ; Cassini, Romina ; Bagaglio, Sabrina ; Morsica, Giulia ; Andreone, Pietro ; Marino, Nicoletta ; Bernardi, Mauro. / Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma. In: Liver International. 2007 ; Vol. 27, No. 8. pp. 1126-1133.
@article{f1d63d8d173940cdabbdac20e501399d,
title = "Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma",
abstract = "Background: The interaction between the hepatitis C virus (HCV) non-structural 5A (NS5A) protein of HCVand the protein kinase R (PKR), which is an effector of the cellular antiviral response and has been defined as a tumour suppressor, may affect the control of protein synthesis and cell growth. Aim: We investigated the genetic evolution of the NS5A region in the NS5A PKR-binding domain (NS5APKRbd) of patients with HCV 1b-related cirrhosis who subsequently developed or not hepatocellular carcinoma (HCC). Patients and Methods: The quasispecies composition of NS5A-PKRbd was inferred by sequencing an average of 15 clones per sample in specimens obtained from 26 patients with cirrhosis who developed or not HCC during a follow-up of 5 years. Results: At baseline, 13/17 patients with final HCC and six out of nine patients with cirrhosis who subsequently did not develop HCC harboured a wild-type (wt) strain master sequence. Over time, the prevalence of wt strain was higher in patients who developed HCC with respect to those who maintained the cirrhosis status (15/17 vs 4/9, respectively; P = 0.0166). Conclusion: The maintenance of or evolution to the wt strain of the NS5A domain in cirrhotic patients with final HCC highlights the central role of NS5A protein in the viral life cycle and in the progression of liver disease.",
keywords = "Cirrhosis, Hepatitis C virus, Hepatocellular carcinoma, Non-structural 5 A protein",
author = "{De Mitri}, {Maria Stella} and Romina Cassini and Sabrina Bagaglio and Giulia Morsica and Pietro Andreone and Nicoletta Marino and Mauro Bernardi",
year = "2007",
month = "10",
doi = "10.1111/j.1478-3231.2007.01537.x",
language = "English",
volume = "27",
pages = "1126--1133",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "8",

}

TY - JOUR

T1 - Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma

AU - De Mitri, Maria Stella

AU - Cassini, Romina

AU - Bagaglio, Sabrina

AU - Morsica, Giulia

AU - Andreone, Pietro

AU - Marino, Nicoletta

AU - Bernardi, Mauro

PY - 2007/10

Y1 - 2007/10

N2 - Background: The interaction between the hepatitis C virus (HCV) non-structural 5A (NS5A) protein of HCVand the protein kinase R (PKR), which is an effector of the cellular antiviral response and has been defined as a tumour suppressor, may affect the control of protein synthesis and cell growth. Aim: We investigated the genetic evolution of the NS5A region in the NS5A PKR-binding domain (NS5APKRbd) of patients with HCV 1b-related cirrhosis who subsequently developed or not hepatocellular carcinoma (HCC). Patients and Methods: The quasispecies composition of NS5A-PKRbd was inferred by sequencing an average of 15 clones per sample in specimens obtained from 26 patients with cirrhosis who developed or not HCC during a follow-up of 5 years. Results: At baseline, 13/17 patients with final HCC and six out of nine patients with cirrhosis who subsequently did not develop HCC harboured a wild-type (wt) strain master sequence. Over time, the prevalence of wt strain was higher in patients who developed HCC with respect to those who maintained the cirrhosis status (15/17 vs 4/9, respectively; P = 0.0166). Conclusion: The maintenance of or evolution to the wt strain of the NS5A domain in cirrhotic patients with final HCC highlights the central role of NS5A protein in the viral life cycle and in the progression of liver disease.

AB - Background: The interaction between the hepatitis C virus (HCV) non-structural 5A (NS5A) protein of HCVand the protein kinase R (PKR), which is an effector of the cellular antiviral response and has been defined as a tumour suppressor, may affect the control of protein synthesis and cell growth. Aim: We investigated the genetic evolution of the NS5A region in the NS5A PKR-binding domain (NS5APKRbd) of patients with HCV 1b-related cirrhosis who subsequently developed or not hepatocellular carcinoma (HCC). Patients and Methods: The quasispecies composition of NS5A-PKRbd was inferred by sequencing an average of 15 clones per sample in specimens obtained from 26 patients with cirrhosis who developed or not HCC during a follow-up of 5 years. Results: At baseline, 13/17 patients with final HCC and six out of nine patients with cirrhosis who subsequently did not develop HCC harboured a wild-type (wt) strain master sequence. Over time, the prevalence of wt strain was higher in patients who developed HCC with respect to those who maintained the cirrhosis status (15/17 vs 4/9, respectively; P = 0.0166). Conclusion: The maintenance of or evolution to the wt strain of the NS5A domain in cirrhotic patients with final HCC highlights the central role of NS5A protein in the viral life cycle and in the progression of liver disease.

KW - Cirrhosis

KW - Hepatitis C virus

KW - Hepatocellular carcinoma

KW - Non-structural 5 A protein

UR - http://www.scopus.com/inward/record.url?scp=34548639595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548639595&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2007.01537.x

DO - 10.1111/j.1478-3231.2007.01537.x

M3 - Article

C2 - 17845542

AN - SCOPUS:34548639595

VL - 27

SP - 1126

EP - 1133

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 8

ER -